Health & Biotech 5 thematics to bring the Australian life sciences sector back in from the cold April 22, 2022 The Australian life sciences sector hasn't had a good run in the past year. While the S&P/ASX 200 is up… Weed Week: US seed bank launches 4/20 day NFT collection and Washington has a cannabis tax holiday April 22, 2022 US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in… Going big: Nutritional Growth Solutions executes Asia Pacific strategy with initial rollout of Kiwi-made products April 21, 2022 Special Report: Nutritional Growth Solutions has dispatched its first shipment of New Zealand produced Healthy Heights® Grow Daily 3+ to… Medlab Clinical shares up ~13% after UK trade deal for patented probiotic NRGBiotic April 20, 2022 Special Report: Medlab Clinical share price is soaring ~13.40% today to 11 cents on the back of a trade deal… PharmAust confirms cash boost for Phase 1 trials, with ATO approval for federal R&D refund April 19, 2022 Special Report: The R&D refund provides PAA with timely cash support as it advances its exciting clinical trial pathway. Osteopore expands further into Europe after delivering maiden sale to Spain April 14, 2022 Special Report: Osteopore’s shipment to Spain comes on the heels of its deal in Colombia earlier this week. ASX Health Stocks: EU approval set to open up Wellfully’s knee patch to European markets April 14, 2022 The Lubricen is a tech-enhanced adhesive knee patch that lubricates the joint before, during, and after physical activity. Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly April 14, 2022 In the US, biotech companies that made their IPO debut in 2021 have seen their stock prices shredded. Medlab just axed another Q3 and now the Aussie world beater’s ready to deploy its vast global network April 13, 2022 Special Report: After a solid quarter, Medlab Clinical is also well funded to progress on its pipelines, with cash in… Medlab Clinical set to export first CBD product into the UK market April 12, 2022 Special Report: The NanoCBD will be the first of two CBD programs to be launched by Medlab into the UK… Next» « Previous